These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 16227311

  • 1. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study).
    Terkelsen CJ, Nørgaard BL, Lassen JF, Poulsen SH, Gerdes JC, Sloth E, Gøtzsche LB, Rømer FK, Thuesen L, Nielsen TT, Andersen HR.
    Eur Heart J; 2006 Feb; 27(3):267-75. PubMed ID: 16227311
    [Abstract] [Full Text] [Related]

  • 2. Significance of T-wave amplitude and dynamics at the time of reperfusion in patients with acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Sørensen JT, Murinson MA, Kaltoft AK, Nikus KC, Wagner GS, Terkelsen CJ.
    J Electrocardiol; 2009 Feb; 42(6):677-83. PubMed ID: 19595361
    [Abstract] [Full Text] [Related]

  • 3. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction.
    Terkelsen CJ, Kaltoft AK, Nørgaard BL, Bøttcher M, Lassen JF, Clausen K, Nielsen SS, Thuesen L, Nielsen TT, Bøtker HE, Andersen HR.
    J Electrocardiol; 2009 Feb; 42(1):64-72. PubMed ID: 18984067
    [Abstract] [Full Text] [Related]

  • 4. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.
    Am J Cardiol; 2010 Apr 15; 105(8):1065-9. PubMed ID: 20381654
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Int J Cardiol; 2009 Apr 03; 133(2):173-8. PubMed ID: 18281115
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW.
    Circulation; 2008 Sep 23; 118(13):1335-46. PubMed ID: 18779444
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF.
    Chin Med J (Engl); 2008 Mar 20; 121(6):485-91. PubMed ID: 18364130
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
    Kelbaek H, Terkelsen CJ, Helqvist S, Lassen JF, Clemmensen P, Kløvgaard L, Kaltoft A, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Thuesen L.
    J Am Coll Cardiol; 2008 Mar 04; 51(9):899-905. PubMed ID: 18308157
    [Abstract] [Full Text] [Related]

  • 14. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, Spiewak M, Kochman J, Rudowski R, Opolski G.
    Int J Cardiol; 2007 Feb 14; 115(3):386-90. PubMed ID: 16860415
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L, Høfsten DE, Wachtell K, Mølgaard H, Egstrup K, DANAMI-2 Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):937-43. PubMed ID: 17826373
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, Atsma DE, Schalij MJ, Jukema JW.
    Am J Cardiol; 2009 Mar 15; 103(6):779-84. PubMed ID: 19268731
    [Abstract] [Full Text] [Related]

  • 17. Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T.
    Bonnemeier H, Wiegand UK, Giannitsis E, Schulenburg S, Hartmann F, Kurowski V, Bode F, Tölg R, Katus HA, Richardt G.
    Am Heart J; 2003 Mar 15; 145(3):484-92. PubMed ID: 12660672
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M, Orliński L, Łobos M, Ciesielczyk M, Wlazeł RN, Paradowski MT.
    Pol Merkur Lekarski; 2010 Jun 15; 28(168):444-9. PubMed ID: 20642101
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.